The Road to Toxin-Targeted Therapeutic Antibodies
ABSTRACT Once an infection by a toxin-producing bacterium is well established, therapies such as antibiotics that target bacterial growth may have little impact on the ultimate patient outcome. In such cases, toxin-neutralizing antibodies offer an opportunity to block key virulence factors. New work...
Enregistré dans:
Auteur principal: | Thomas R. Kozel |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3d1bddd1cbb24a0e9caa0a0bec42643f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Antibody-Mediated Inhibition of Ricin Toxin Retrograde Transport
par: Anastasiya Yermakova, et autres
Publié: (2014) -
Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious <named-content content-type="genus-species">Staphylococcus aureus</named-content> Disease
par: C. Tkaczyk, et autres
Publié: (2016) -
Global Analysis of the Specificities and Targets of Endoribonucleases from Escherichia coli Toxin-Antitoxin Systems
par: Peter H. Culviner, et autres
Publié: (2021) -
New Players in the Toxin Field: Polymorphic Toxin Systems in Bacteria
par: Anne Jamet, et autres
Publié: (2015) -
Modular Lipoprotein Toxins Transferred by Outer Membrane Exchange Target Discrete Cell Entry Pathways
par: Christopher N. Vassallo, et autres
Publié: (2021)